Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Aug 29, 2013

30071_dirs_2013-08-29_ae78b052-c841-483f-9edd-1e1d26a5afb5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-08-27

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-08-27 ResMed Common Stock M 5000 $23.875 Acquired 94012.16 Direct
2013-08-27 ResMed Common Stock S 5000 $49.00 Disposed 89012.16 Direct
2013-08-27 ResMed Common Stock M 20000 $15.520 Acquired 109012.16 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-08-27 ResMed NQ Stock Options $15.520 M 20000 Disposed 2015-11-20 ResMed Common Stock (20000) Direct
2013-08-27 ResMed NQ Stock Options $23.875 M 5000 Disposed 2016-07-07 ResMed Common Stock (5000) Direct

Footnotes

F1: Represents date options first became exercisable. Options vest 1/4 each year.